EarningsQ3 2024 Earnings Report

Protagonist Therapeutics (PGF) Q3 2024 Earnings Report

1 Followers

DE:PGF Q3 2024 EPS Results

Actual EPS-€0.48

Consensus EPS-€0.52

Beat/MissBeat by +€0.03

One Year Ago EPS-€0.52

Actual Revenue€4.17M

Expected Revenue€2.77M

Beat/MissBeat by +€1.39M

YoY Revenue Growth―

QuarterQ3 2024

Date11/07/2024

TimeAfter Close

Conference CallThursday, November 7, 2024

DE:PGF Upcoming Earnings

Protagonist Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	2.17 / -	-0.553	―
Aug 05, 2026	2026 (Q2)	1.97 / 2.04	-0.49	516.36% (+2.53)
May 05, 2026	2026 (Q1)	-0.41 / 0.04	-0.169	126.32% (+0.21)
Feb 25, 2026	2025 (Q4)	-0.51 / -0.61	1.765	-134.85% (-2.38)
Nov 06, 2025	2025 (Q3)	-0.56 / -0.55	-0.481	-14.81% (-0.07)
Aug 06, 2025	2025 (Q2)	-0.52 / -0.49	-0.446	-10.00% (-0.04)
Apr 30, 2025	2025 (Q1)	-0.17 / -0.16	2.906	-105.67% (-3.07)
Feb 21, 2025	2024 (Q4)	1.03 / 1.76	0.392	350.00% (+1.37)
Nov 07, 2024	2024 (Q3)	-0.52 / -0.48	-0.517	6.90% (+0.04)
Aug 06, 2024	2024 (Q2)	-0.53 / -0.45	-0.606	26.47% (+0.16)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed